Research has shown that the proton pump inhibitor omeprazole can downregulate FTO and inhibit pro-survival autophagy in GC, thereby increasing the efficacy of chemotherapeutic agents and synergizing with antitumor medications [106]. Here, FTO is linked to gastric cancer.